学術雑誌論文 Epstein-Barr virus-associated leukemic lymphoma after allogeneic stem cell transplantation

Takamatsu, Hiroyuki  ,  Araki, Raita  ,  Nishimura, Ryosei  ,  Yachie, Akihiro  ,  Espinoza, J. Luis  ,  Okumura, Hirokazu  ,  Yoshida, Takashi  ,  Kuzushima, Kiyotaka  ,  Nakao, Shinji

80pp.82 - 86 , 2016-06-01 , Elsevier
ISSN:1386-6532
NII書誌ID(NCID):AA11281494
内容記述
Leukemic Epstein-Barr virus (EBV)-associated post-transplant lymphoproliferative diseases (PTLD) following allogeneic hematopoietic stem cell transplantation are extremely rare. We can successfully treat an EBV-associated leukemic lymphoma patient with rituximab, cidofovir, and donor lymphocyte infusion (DLI). In the present case, EBV-specific T cells that were present in the peripheral blood before rituximab administration treatment rapidly increased after DLI in association with a decrease in the EBV-DNA load. © 2016 Elsevier B.V.
Embargo Period 12 months
本文を読む

https://kanazawa-u.repo.nii.ac.jp/?action=repository_action_common_download&item_id=14353&item_no=1&attribute_id=26&file_no=1

このアイテムのアクセス数:  回

その他の情報